麻豆国产精品一二三在线观-麻豆国产精品一二三在线观看-麻豆国产精品一区二区-麻豆国产精品永久免费视频-麻豆国产巨作av剧情-麻豆国产蜜桃臀视频在线观看

荷蘭Cruinn  
Cruinn Diagnostics Ltd. was established in 1998 and has grown to become one of Ireland's leading suppliers in the Laboratory, Medical and Healthcare markets in Ireland. Cruinn's philosophy is to provide quality products in partnership with world class market leaders. Our key objective is to provide integrated product solutions that provide added value from a single supplier.

Our product portfolio covers a wide range of Diagnostics including Microbiology, AutoImmune Serology, Clinical Chemistry, Immunoassay, with the recent introduction of Real Time Molecular Diagnostics. Other product lines include Blood Collection Systems, POC, Medical Devices, Liquid handling Consumables and Instrumentation/Automation, Healthcare IT Systems, Consumables and Calibration/Validation Services.

Sales support is provided by a dedicated team of professionals who provide full account management for the customer. Our Sales Team provide a direct line of communication back to Cruinn so that customers requirements and expectations are realised.

The Sales Team is supported by a dedicated team of Customer Support Representatives. Our customer support team are always available to take your call and deal with any enquiries that you have. This group manages a comprehensive order processing system where all orders are processed on the day of receipt.

Cruinn Diagnostics Ltd. also provide a team of dedicated product support specialist teams for each product group and their aim is to keep the customer informed of new product releases, new technologies and provide support to the customer using extensive product knowledge at customer site locations. Extensive training is also provided by Cruinn Diagnostics which help to implement new and emerging technologies in the various product portfolios.

Cruinn Diagnostics Ltd. is certified to ISO9001:2000. Products designed for clinical market are supplied in accordance with the European IVD Directive and carry the CE mark.